Key result
Targeting vascular aging with lifestyle and drug interventions may mitigate cardiovascular, kidney, and brain disease progression.
Why the study?
The increasing hospitalization rates due to vascular aging-related diseases highlight the urgent need for effective interventions to counteract vascular function decline.
May inform preventive strategies for vascular aging-related diseases; leaves open targeted interventional trials.
The aging-related factors of population, environment, physical inactivity and unhealthy diet have emerged as significant contributors to the onset of vascular aging, which poses a crucial risk for various diseases including hypertension, coronary heart disease, heart failure and stroke. The structural, phenotypic, and functional changes in vasculature resulting from aging are critical in the pathogenesis of vascular aging-related diseases. Numerous molecular and cellular phenomena, including oxidative stress, mitochondrial dysfunction, vascular inflammation, cellular senescence, and epigenetic alterations, are closely linked to the pathophysiology of vascular aging. Given the escalating hospitalization rates attributed to vascular aging-related illness, the need for efficacious interventions to counteract the decline in vascular function is becoming increasingly pressing. This review provides an overview of recent developments in vascular aging-related disorders, encompassing cardiovascular diseases, neurodegenerative diseases, chronic kidney diseases, and sarcopenia. Furthermore, a comprehensive examination of the pathogenesis of aging is conducted, and the implementation of intervention strategies (including drug and lifestyle interventions) can effectively mitigate the onset and progression of aging-related ailments, thereby facilitating the achievement of healthy aging and longevity.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted a review in Vascular aging-related diseases. Vascular aging and targeted interventions was evaluated. Vascular aging is a crucial risk factor for cardiovascular, neurodegenerative, and kidney diseases, and targeted pharmacological and lifestyle interventions may mitigate the progression of these ailments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: